Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
COGT | Cogent Biosciences, Inc. | Director | $321 K | Jun 5, 2024 | ||
EPZM | Epizyme, Inc. | Executive Vice President, Chief Strategy & Business Officer | $232 K | Aug 16, 2021 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|